Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Immunogenicity of One Versus Two Doses of Killed Oral Cholera Vaccine

This study has been completed.
Sponsor:
Collaborators:
National Institute of Cholera and Enteric Diseases, India
Shantha Biotechnics Limited
Information provided by:
International Vaccine Institute
ClinicalTrials.gov Identifier:
NCT00419133
First received: January 4, 2007
Last updated: December 4, 2009
Last verified: December 2009